BPBT
KIN

Boston Private Bank & Trust’s Kindred Biosciences, Inc. KIN Stock Holding History

Boston Private Bank & Trust’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$5K Hold
700
– – ﹤0.01% 905
2014
Q4 		$5K Hold
700
– – ﹤0.01% 973
2014
Q3 		$6K Buy
+700
New +$9.46K ﹤0.01% 937

Other funds holding KIN

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Boston Private Bank & Trust's KIN Position: Q1 2015 in Review

Boston Private Bank & Trust held its Kindred Biosciences, Inc. (KIN) position steady in Q1 2015 at 700 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #905.

Boston Private Bank & Trust first reported a position in KIN in Q3 2014 and has held it in 3 quarters since. The position peaked at $6K in Q3 2014. 60 funds tracked by Wall St. Rank hold KIN as of Q1 2015.

  • Boston Private Bank & Trust held 700 shares of Kindred Biosciences, Inc. worth $5K as of Q1 2015.
  • Boston Private Bank & Trust left its Kindred Biosciences, Inc. share count unchanged in Q1 2015.
  • Kindred Biosciences, Inc. made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #905 holding.
  • Boston Private Bank & Trust first reported a position in Kindred Biosciences, Inc. in Q3 2014 and has held it in 3 quarters since.
  • Boston Private Bank & Trust's Kindred Biosciences, Inc. position peaked at $6K in Q3 2014.
  • 60 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.